Skip to main content

Aratana shareholders approve company's sale for $245M

The acquisition of Aratana Therapeutics Inc. marks a success story for a locally founded animal health company, even as it reduces the number public companies based in Kansas City.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.